On the last day of trading for <a class="manualbacklink" target="_blank" href="https://mintgenie.livemint.com/stocks/alembic-pharmaceuticals-S0003266">Alembic Pharmaceuticals</a> on the Bombay Stock Exchange (BSE), the volume of shares traded was 5868. The closing price for the day was ₹773.95.

Alembic Pharmaceuticals share price Live :Alembic Pharmaceuticals trading at ₹770.9, down -0.39% from yesterday's ₹773.95

Alembic Pharmaceuticals Share Price Live blog for 01 Aug 2023

Alembic Pharmaceuticals had an open price of ₹776.05 and a close price of ₹773.95 on the last trading day. The stock reached a high of ₹776.15 and a low of ₹763.05. The market capitalization of the company is ₹15,153.05 crore. In the past 52 weeks, the stock has reached a high of ₹793.10 and a low of ₹463.30. The BSE volume for the day was 5868 shares.Disclaimer: This is an AI-generated live blog and has not been edited by MintGenie staff.

Alembic Pharmaceuticals stock price went down today, 01 Aug 2023, by -0.39 %. The stock closed at 773.95 per share. The stock is currently trading at 770.9 per share. Investors should monitor Alembic Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.

Angel One share price Today Live Updates : Angel One Stock Plunges in Today's Trading

Exide Industries share price Today Live Updates : Exide Industries sees stock gains as trading turns positive

Aurobindo Pharma Share Price Live blog for 01 Aug 2023

Capri Global Capital Share Price Live blog for 01 Aug 2023

Dixon Technologies (India) share price Today Live Updates : Dixon Technologies (India) sees positive trading day

ABB India Share Price Live blog for 01 Aug 2023

Balaji Amines share price Today Live Updates : Balaji Amines sees bullish trading today

Coromandel International share price Today Live Updates : Coromandel International's Stock Soars on Positive Trading Day

Biocon Share Price Live blog for 01 Aug 2023

HDFC Securities sees over 70% upside in Ashoka Buildcon; says asset value is greater than mcap

Ashoka Buildcon's order book has multiplied 2x over FY19-23, but its shares have underperformed. HDFC Securities maintains a 'buy' rating, with a revised target price of ₹189, citing a strong order book and anticipated cash inflows from asset monetisation.

Nomura cautious on Asia but ‘overweight’ on India; lists out top stock picks

Nomura has upgraded India to 'overweight' from 'neutral', citing its structural story as a major beneficiary of the ‘China+1’ theme and a large, liquid equity market. Nomura recommends a portfolio of stocks with favourable valuations and exposure to domestic growth sectors like banks and infra.

Top 5 banks offering most competitive home loan interest rates

Home loan interest rates have now risen to around 8.75 to 9 percent after the RBI raised repo rates six times since May 2022. However, these top banks are offering the interest rates that are lower than 9 percent per annum.

Global Health: Motilal Oswal initiates coverage on this newly listed stock with a 'buy' rating

Medanta, the hospital operator, receives 'buy' rating from Motilal Oswal with a target price of ₹840, implying a 21% upside potential.

Adani Ports Stock Check: Up 41% in 7 months, should you still buy the stock?

Adani Ports has rebounded strongly, gaining over 41% between March and September after falling earlier this year. Despite recent allegations of improper business dealings, analysts maintain positive views on the stock. Let's look at the technical and fundamental outlook of the stock.